AI and Brain Aging: Implications for Amblyopia Therapy

Artificial intelligence is increasingly being used to analyze brain scans and estimate a person’s “brain age”—a measure of how well the brain has aged relative to chronological years. When brain age exceeds actual age, it may signal accelerated aging or increased risk for neurological decline. For individuals with amblyopia, or lazy eye, this technology raises intriguing questions about how visual deprivation during development affects the brain over a lifetime.

Amblyopia is traditionally treated in childhood by patching the stronger eye to force use of the weaker one, capitalizing on neuroplasticity. However, recent research suggests that the brain’s visual system remains more plastic than once thought, even into adulthood. AI-based brain age analysis could help identify which patients’ brains are aging faster, potentially guiding more personalized or extended therapy. For example, if a patient’s brain appears older than expected, clinicians might consider additional interventions to support neural health.

What This Means for Patients

While these tools are not yet standard in eye care, they represent a frontier in understanding the long-term effects of amblyopia. Some studies indicate that untreated amblyopia may be associated with changes in brain structure beyond the visual cortex, possibly contributing to faster brain aging. AI could eventually help monitor these changes and evaluate whether therapy is having a protective effect. However, it is important to note that brain age estimates are research tools, not diagnostic tests.

Patients and families should discuss any concerns about brain health or aging with their eye-care professional. An ophthalmologist or optometrist can provide guidance on current amblyopia treatments and refer to specialists if needed. As AI continues to evolve, it may offer new ways to assess and improve outcomes for amblyopia, but for now, established therapies remain the cornerstone of care.